Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estrogen for Asymptomatic Microhematuria
NCT02213757Phase 4Terminated
- Sponsor
- MedStar Health Research Institute
- Start
- Aug 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in microscopic hematuria comparing Premarin vaginal cream with Placebo vaginal cream (2 arms). Primary endpoint: Number of Participants With Resolution of Microscopic Hematuria at 8 weeks. Started Aug 2014; status: terminated.
02
Drugs
Estrogen vaginal cream
03
Conditions
microscopic hematuria
Beyond the preview
Go deeper on NCT02213757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213757.